224 related articles for article (PubMed ID: 24503789)
21. Relationship between response to induction chemotherapy and disease control in patients with advanced laryngeal carcinoma included in an organ preservation protocol.
León X; Valero C; Rovira C; Rodriguez C; López M; García-Lorenzo J; Quer M
Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2581-2587. PubMed ID: 28349204
[TBL] [Abstract][Full Text] [Related]
22. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer.
; Pfister DG; Laurie SA; Weinstein GS; Mendenhall WM; Adelstein DJ; Ang KK; Clayman GL; Fisher SG; Forastiere AA; Harrison LB; Lefebvre JL; Leupold N; List MA; O'Malley BO; Patel S; Posner MR; Schwartz MA; Wolf GT
J Clin Oncol; 2006 Aug; 24(22):3693-704. PubMed ID: 16832122
[TBL] [Abstract][Full Text] [Related]
23. A single-institutional experience of 15 years of treating T3 laryngeal cancer with primary radiotherapy, with or without chemotherapy.
Al-Mamgani A; Tans L; van Rooij P; Levendag PC
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1000-6. PubMed ID: 22099030
[TBL] [Abstract][Full Text] [Related]
24. [Management of T3 supraglottic carcinoma: a retrospective study].
Liu WS; Li ZJ; Zhang GF; Xu ZG; Tang PZ; Tu GY
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):613-617. PubMed ID: 28835085
[No Abstract] [Full Text] [Related]
25. Transoral laser microsurgery in treatment of pT2 and pT3 glottic laryngeal squamous cell carcinoma - results of 391 patients.
Canis M; Martin A; Ihler F; Wolff HA; Kron M; Matthias C; Steiner W
Head Neck; 2014 Jun; 36(6):859-66. PubMed ID: 23720321
[TBL] [Abstract][Full Text] [Related]
26. Organ preservation for adenoid cystic carcinoma of the larynx.
Misiukiewicz KJ; Camille N; Tishler R; Haddad R; Limaye S; Posner M
Oncologist; 2013; 18(5):579-83. PubMed ID: 23615699
[TBL] [Abstract][Full Text] [Related]
27. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
[TBL] [Abstract][Full Text] [Related]
28. Total laryngectomy and postoperative radiotherapy for T4 laryngeal cancer: a 14-year review.
Ampil FL; Nathan CO; Caldito G; Lian TF; Aarstad RF; Krishnamsetty RM
Am J Otolaryngol; 2004; 25(2):88-93. PubMed ID: 14976652
[TBL] [Abstract][Full Text] [Related]
29. Surgical treatment of laryngeal carcinoma with subglottis involvement.
Chiesa F; Tradati N; Calabrese L; Zurrida S; DePaoli F; Costa L; Molinari R
Oncol Rep; 2001; 8(1):137-40. PubMed ID: 11115585
[TBL] [Abstract][Full Text] [Related]
30. Supracricoid partial laryngectomy for primary and recurrent laryngeal cancer.
Sperry SM; Rassekh CH; Laccourreye O; Weinstein GS
JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1226-35. PubMed ID: 24092390
[TBL] [Abstract][Full Text] [Related]
31. Horizontal supraglottic partial laryngectomy for selected squamous carcinoma of the vallecula.
Laccourreye L; Garcia D; Ménard M; Brasnu D; Laccourreye O; Holsinger FC
Head Neck; 2008 Jun; 30(6):756-64. PubMed ID: 18286490
[TBL] [Abstract][Full Text] [Related]
32. Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3-T4: 5-year oncologic results.
Laccourreye O; Brasnu D; Biacabe B; Hans S; Seckin S; Weinstein G
Head Neck; 1998 Oct; 20(7):595-9. PubMed ID: 9744458
[TBL] [Abstract][Full Text] [Related]
33. One hundred supracricoid laryngectomies with cricohyoidoepiglottopexy: do we achieve better local control?
Nakayama M; Miyamoto S; Seino Y; Okamoto T; Kano K; Hasebe M; Okamoto M
Jpn J Clin Oncol; 2015 Aug; 45(8):732-7. PubMed ID: 25981622
[TBL] [Abstract][Full Text] [Related]
34. [The results and toxicity of organ preservation treatment for locoregionally advanced laryngeal and hypopharyngeal cancer].
Kiprian D; Kawecki A; Jarząbski A; Michalski W; Pawłowska-Sendułka B
Otolaryngol Pol; 2011; 65(5):363-8. PubMed ID: 22078287
[TBL] [Abstract][Full Text] [Related]
35. Induction chemotherapy-based larynx preservation program for locally advanced hypopharyngeal cancer: oncologic and functional outcomes and prognostic factors.
Bozec A; Benezery K; Ettaiche M; Chamorey E; Vandersteen C; Dassonville O; Poissonnet G; Riss JC; Hannoun-Lévi JM; Chand ME; Leysalle A; Saada E; Guigay J; Sudaka A; Demard F; Santini J; Peyrade F
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3299-306. PubMed ID: 26858198
[TBL] [Abstract][Full Text] [Related]
36. Endoscopic carbon dioxide laser surgery for glottic cancer recurrence after radiotherapy: oncological results.
Ansarin M; Planicka M; Rotundo S; Santoro L; Zurlo V; Maffini F; Alterio D; Cattaneo A; Chiesa F
Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1193-7. PubMed ID: 18086959
[TBL] [Abstract][Full Text] [Related]
37. Treatment outcomes of the patients with early glottic cancer treated with initial radiotherapy and salvaged by conservative surgery.
Harada A; Sasaki R; Miyawaki D; Yoshida K; Nishimura H; Ejima Y; Kitajima K; Saito M; Otsuki N; Nibu K
Jpn J Clin Oncol; 2015 Mar; 45(3):248-55. PubMed ID: 25502310
[TBL] [Abstract][Full Text] [Related]
38. Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer. A long-term follow-up report.
Karp DD; Vaughan CW; Carter R; Willett B; Heeren T; Calarese P; Zeitels S; Strong MS; Hong WK
Am J Clin Oncol; 1991 Aug; 14(4):273-9. PubMed ID: 1713738
[TBL] [Abstract][Full Text] [Related]
39. [The value of supracricoid partial laryngectomy in moderately advanced laryngeal cancer (T3-T4a)].
Schroeder U; Wollenberg B; Bruchhage KL
HNO; 2015 Nov; 63(11):741-6. PubMed ID: 26452490
[TBL] [Abstract][Full Text] [Related]
40. [Traditional transcutaneous approaches in head & neck surgery].
Gößler UR
Laryngorhinootologie; 2012 Mar; 91 Suppl 1():S63-85. PubMed ID: 22456920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
